SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

Rocket Pharmaceuticals Q1 EPS $(0.65) Down From $(0.45) YoY

Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.65) per share. This is a 44.44 percent decrease over losses of $(0.45) per share from the same period last year.

05/10/2021 16:04
Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.65) per share. This is a 44.44 percent decrease over losses of $(0.45) per share from the same period last year.